Tenaya Therapeutics IncNASDAQ:TNYA
- LAST PRICE4.6200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 4.6200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNYA |
|---|---|---|
| 09:32 ET | 4367 | 4.75 |
| 09:34 ET | 100 | 4.755 |
| 09:36 ET | 1100 | 4.76 |
| 09:41 ET | 2300 | 4.7 |
| 09:43 ET | 100 | 4.73 |
| 09:45 ET | 101 | 4.67 |
| 09:48 ET | 692 | 4.665 |
| 09:52 ET | 100 | 4.67 |
| 09:54 ET | 200 | 4.66 |
| 09:57 ET | 100 | 4.69 |
| 10:01 ET | 642 | 4.69 |
| 10:03 ET | 215 | 4.71 |
| 10:10 ET | 900 | 4.68 |
| 10:12 ET | 300 | 4.7 |
| 10:14 ET | 100 | 4.719 |
| 10:19 ET | 828 | 4.72 |
| 10:26 ET | 100 | 4.72 |
| 10:30 ET | 300 | 4.74 |
| 10:33 ET | 100 | 4.759 |
| 10:39 ET | 205 | 4.749 |
| 10:42 ET | 405 | 4.7291 |
| 10:46 ET | 200 | 4.75 |
| 10:50 ET | 100 | 4.75 |
| 10:51 ET | 2100 | 4.735 |
| 10:53 ET | 300 | 4.75 |
| 10:55 ET | 1303 | 4.705 |
| 11:02 ET | 100 | 4.71 |
| 11:04 ET | 100 | 4.73 |
| 11:09 ET | 200 | 4.75 |
| 11:15 ET | 200 | 4.75 |
| 11:20 ET | 100 | 4.749 |
| 11:22 ET | 100 | 4.75 |
| 11:24 ET | 100 | 4.75 |
| 11:29 ET | 100 | 4.75 |
| 11:33 ET | 200 | 4.77 |
| 11:36 ET | 200 | 4.77 |
| 11:38 ET | 1200 | 4.755 |
| 11:42 ET | 200 | 4.79 |
| 11:44 ET | 100 | 4.79 |
| 11:47 ET | 200 | 4.79 |
| 11:51 ET | 100 | 4.79 |
| 11:54 ET | 100 | 4.79 |
| 12:00 ET | 300 | 4.785 |
| 12:05 ET | 308 | 4.77 |
| 12:07 ET | 1500 | 4.75 |
| 12:09 ET | 742 | 4.72 |
| 12:12 ET | 287 | 4.74 |
| 12:14 ET | 100 | 4.725 |
| 12:18 ET | 100 | 4.725 |
| 12:21 ET | 100 | 4.74 |
| 12:23 ET | 468 | 4.725 |
| 12:32 ET | 100 | 4.725 |
| 12:34 ET | 3317 | 4.69 |
| 12:45 ET | 500 | 4.679 |
| 12:50 ET | 241 | 4.66 |
| 12:54 ET | 200 | 4.69 |
| 12:56 ET | 100 | 4.66 |
| 12:59 ET | 118 | 4.66 |
| 01:01 ET | 100 | 4.675 |
| 01:03 ET | 1977 | 4.635 |
| 01:06 ET | 102 | 4.644 |
| 01:08 ET | 4940 | 4.65 |
| 01:14 ET | 1300 | 4.655 |
| 01:15 ET | 100 | 4.655 |
| 01:17 ET | 200 | 4.654 |
| 01:19 ET | 700 | 4.645 |
| 01:21 ET | 1024 | 4.65 |
| 01:24 ET | 300 | 4.664 |
| 01:26 ET | 100 | 4.67 |
| 01:28 ET | 580 | 4.679 |
| 01:30 ET | 100 | 4.68 |
| 01:33 ET | 600 | 4.67 |
| 01:35 ET | 257 | 4.68 |
| 01:37 ET | 1292 | 4.69 |
| 01:42 ET | 900 | 4.67 |
| 01:44 ET | 100 | 4.66 |
| 01:50 ET | 214 | 4.64 |
| 01:51 ET | 100 | 4.64 |
| 01:57 ET | 552 | 4.63 |
| 02:00 ET | 200 | 4.62 |
| 02:06 ET | 817 | 4.64 |
| 02:08 ET | 669 | 4.68 |
| 02:09 ET | 300 | 4.66 |
| 02:15 ET | 300 | 4.66 |
| 02:18 ET | 600 | 4.64 |
| 02:22 ET | 240 | 4.64 |
| 02:26 ET | 100 | 4.63 |
| 02:27 ET | 100 | 4.61 |
| 02:29 ET | 100 | 4.61 |
| 02:31 ET | 847 | 4.62 |
| 02:33 ET | 156 | 4.6 |
| 02:36 ET | 148 | 4.6 |
| 02:40 ET | 300 | 4.6 |
| 02:42 ET | 500 | 4.619 |
| 02:44 ET | 1312 | 4.6 |
| 02:45 ET | 900 | 4.63 |
| 02:51 ET | 205 | 4.66 |
| 02:54 ET | 200 | 4.66 |
| 02:58 ET | 379 | 4.66 |
| 03:00 ET | 2261 | 4.63 |
| 03:02 ET | 100 | 4.65 |
| 03:03 ET | 1295 | 4.63 |
| 03:05 ET | 200 | 4.63 |
| 03:07 ET | 586 | 4.64 |
| 03:09 ET | 700 | 4.634 |
| 03:12 ET | 100 | 4.64 |
| 03:16 ET | 400 | 4.634 |
| 03:18 ET | 400 | 4.63 |
| 03:20 ET | 100 | 4.62 |
| 03:21 ET | 718 | 4.64 |
| 03:25 ET | 200 | 4.64 |
| 03:27 ET | 200 | 4.63 |
| 03:30 ET | 1100 | 4.61 |
| 03:32 ET | 472 | 4.62 |
| 03:36 ET | 525 | 4.62 |
| 03:38 ET | 604 | 4.61 |
| 03:43 ET | 396 | 4.61 |
| 03:45 ET | 100 | 4.6 |
| 03:48 ET | 300 | 4.615 |
| 03:50 ET | 1233 | 4.61 |
| 03:52 ET | 661 | 4.61 |
| 03:54 ET | 200 | 4.61 |
| 03:56 ET | 2779 | 4.6184 |
| 03:57 ET | 1500 | 4.61 |
| 03:59 ET | 4525 | 4.62 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tenaya Therapeutics Inc | 367.5M | -2.7x | --- |
Erasca Inc | 362.3M | -2.6x | --- |
Solid Biosciences Inc | 360.2M | -2.1x | --- |
Skye Bioscience Inc | 358.9M | -2.3x | --- |
Aura Biosciences Inc | 378.7M | -4.0x | --- |
Nautilus Biotechnology Inc | 347.8M | -4.9x | --- |
Company Information
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.
Contact Information
- Headquarters
- 171 Oyster Point Blvd., Suite 500SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 415-865-2066
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Goeddel
- Chief Executive Officer, Director
- Faraz Ali
- Chief Financial and Business Officer
- Leone Patterson
- Chief Scientific Officer
- Timothy Hoey
- Chief Medical Officer
- Whittemore Tingley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $362.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 78.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.68 |
Book Value | $2.04 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
